2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
2016 | | Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients | 박준성, 이위교, 임영애, 정성현, 조성란 |
1996 | | Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. | 김진홍, 김효철, 이광재, 조성원, 함기백 |
2023 | | Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation | 정성현, 최윤석 |
2013 | | Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer. | 강두경, 강석윤, 김구상, 김지영, 김태희, 박래웅, 안미선, 안영실, 임현이, 전자영, 정용식 |
2022 | | Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations | 안미선 |
2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments | 강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환 |
2023 | | Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) | 최진혁 |
2023 | | Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response | 권민석 |
2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
2009 | | Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer | 강석윤, 박광주, 신승수, 안미선, 오영택, 이현우, 정성현, 최진혁 |
1996 | | Concurrent presentation of erythrocytic and megakaryocytic aplasia. | 김효철 |
2018 | | Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment | 이현우 |
2021 | | Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488] | 강석윤 |
2021 | | Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux | 김철호, 박준성, 정성현, 최용원 |
2013 | | Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea | 박준성, 박준은, 이현우, 정성현, 조성란 |
2023 | | Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404) | 정성현 |
2020 | | DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network | 이현우 |